Meyka Pro banner
Leafly Holdings, Inc.

Leafly Holdings, Inc. (NASDAQ: LFLYW) Stock Competitors & Peer Comparison

See LFLYW's competitors and their performance on the NASDAQ and across the wider stock market.

LFLYWNASDAQ
HealthcareMedical - Pharmaceuticals
$0.004
$0.005(57.89%)
U.S. Market opens in 12h 37m

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for LFLYW and its NASDAQ peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LFLYW$0.00-57.89%299.9K-0.00-$1.44N/A
RPRX$57.60+0.59%25.2B10.81$5.25+1.60%
CORT$114.16+5.75%12B316.49$0.35N/A
WBA$11.98+0.50%10.4B-1.64-$7.29+4.17%
LQDA$88.68-0.83%8B644.43$0.14N/A
KNSA$76.88+0.48%5.8B84.51$0.90N/A
TRLV$9.07+0.75%1.5B-20.83-$0.42N/A
HROWL$25.61+0.19%1.4BN/AN/AN/A
HROWM$26.03-0.08%1.3BN/AN/AN/A
CUVL$6.74+0.24%336.6MN/AN/AN/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Royalty Pharma plc (NASDAQ: RPRX)

LFLYW vs RPRX Comparison August 2026

Leafly Holdings, Inc. (NASDAQ: LFLYW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LFLYW stands at 299.9K. In comparison, RPRX has a market cap of 25.2B. Regarding current trading prices, LFLYW is priced at $0.00 on the NASDAQ, while RPRX trades at $57.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LFLYW currently has a P/E ratio of -0.00, whereas RPRX's P/E ratio is 10.81. In terms of profitability, LFLYW's ROE is +0.42%, compared to RPRX's ROE of +0.11%. Regarding short-term risk, LFLYW is less volatile compared to RPRX. This indicates lower risk in terms of short-term price fluctuations for LFLYW.Check RPRX's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions